Clinical Trials · NCT07576036

International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia

Name: International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Enrolling By InvitationN/ADesmopressin

Phase: N/A
Recruitment status: Enrolling By Invitation
Sponsor: Rochester General Hospital
Enrollment: 800
Start date: Nov 2023
Locations: 1 site, United States
Primary endpoint: Osmotic demyelination syndrome

View Desmopressin compound reference